The objective of this study was to evaluate the pharmacokinetic parameters of triflusal and its major active metabolite , 2-hydroxy-4-trifluoromethyl benzoic acid ( HTB ) , following a single oral dose of 900 mg in healthy subjects under fed and fasting conditions .